- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Impedimed Ltd (IPD)
Impedimed Ltd stock price live, this page displays ASX IPD stock exchange data. View the IPD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Impedimed Ltd real time stock price chart below.
What Is the Impedimed Ltd Stock Price Today?
The Impedimed Ltd stock price today is 0.050.
What Is the Stock Symbol for Impedimed Ltd?
The stock symbol for Impedimed Ltd is ""IPD.""
What Stock Exchange Does Impedimed Ltd Trade On?
Impedimed Ltd is listed and trades on the Sydney stock exchange.
Is Impedimed Ltd a Good Stock to Buy?
Determining whether Impedimed Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IPD quote. (ISIN: AU000000IPD8)
What Is the Impedimed Ltd Stock Price Today?
The Impedimed Ltd stock price today is 0.050.
What Is the Stock Symbol for Impedimed Ltd?
The stock symbol for Impedimed Ltd is ""IPD.""
What Stock Exchange Does Impedimed Ltd Trade On?
Impedimed Ltd is listed and trades on the Sydney stock exchange.
Is Impedimed Ltd a Good Stock to Buy?
Determining whether Impedimed Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IPD quote. (ISIN: AU000000IPD8)
Sydney
Currency in AUD
0.050
+0.003(+6.38%)
Closed·
Fair Value
An estimate of a Impedimed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.045
0.050
52 wk Range
0.026
0.068
IPD Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
Unusual trading volume
1/2
Fair Value
An estimate of a Impedimed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0450.050
52 wk Range
0.0260.068
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IPD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Impedimed's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
0.110
Upside
+120.28%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Impedimed Ltd receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Impedimed Ltd Company Profile
ImpediMed Limited, a medical technology company, develops, manufactures and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-care body composition analysis; and HF-Dex analysis for point-of-care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. ImpediMed Limited was incorporated in 1999 and is headquartered in Carlsbad, California with additional office in Lindfield, Australia.
Compare IPD to Peers and Sector
Metrics to compare | IPD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIPDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.4x | −3.9x | −0.6x | |
PEG Ratio | 0.25 | −0.04 | 0.00 | |
Price/Book | 5.0x | 1.3x | 2.6x | |
Price / LTM Sales | 8.0x | 1.7x | 3.4x | |
Upside (Analyst Target) | 140.0% | 44.2% | 35.5% | |
Fair Value Upside | Unlock | −2.4% | 3.7% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.110
(+120.28% Upside)
Earnings
Latest Release
Aug 27, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
3.30M / 5.30M
People Also Watch
FAQ
What Stock Exchange Does Impedimed Trade On?
Impedimed is listed and trades on the Sydney Stock Exchange stock exchange.
What Is the Stock Symbol for Impedimed?
The stock symbol for Impedimed is "IPD."
What Is the Impedimed Market Cap?
As of today, Impedimed market cap is 101.81M.
What Is Impedimed's Earnings Per Share (TTM)?
The Impedimed EPS (TTM) is -0.01.
When Is the Next Impedimed Earnings Date?
Impedimed will release its next earnings report on 22 Oct 2025.
From a Technical Analysis Perspective, Is IPD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Impedimed Stock Split?
Impedimed has split 6 times.
How Many Employees Does Impedimed Have?
Impedimed has 77 employees.
What is the current trading status of Impedimed (IPD)?
As of 05 Oct 2025, Impedimed (IPD) is trading at a price of 0.050, with a previous close of 0.05. The stock has fluctuated within a day range of 0.045 to 0.050, while its 52-week range spans from 0.026 to 0.068.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.